These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17922407)

  • 21. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy.
    Hauber I; Bevec D; Heukeshoven J; Krätzer F; Horn F; Choidas A; Harrer T; Hauber J
    J Clin Invest; 2005 Jan; 115(1):76-85. PubMed ID: 15630446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation.
    McClure J; Lovelace ES; Elahi S; Maurice NJ; Wagoner J; Dragavon J; Mittler JE; Kraft Z; Stamatatos L; Horton H; De Rosa SC; Coombs RW; Polyak SJ
    PLoS One; 2012; 7(7):e41832. PubMed ID: 22848626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity.
    Margolis D; Heredia A; Gaywee J; Oldach D; Drusano G; Redfield R
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):362-70. PubMed ID: 10458616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.
    Ylisastigui L; Coull JJ; Rucker VC; Melander C; Bosch RJ; Brodie SJ; Corey L; Sodora DL; Dervan PB; Margolis DM
    J Infect Dis; 2004 Oct; 190(8):1429-37. PubMed ID: 15378435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New targets for inhibitors of HIV-1 replication.
    Moore JP; Stevenson M
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino functionalized novel cholic acid derivatives induce HIV-1 replication and syncytia formation in T cells.
    Salunke DB; Ravi DS; Pore VS; Mitra D; Hazra BG
    J Med Chem; 2006 Apr; 49(8):2652-5. PubMed ID: 16610808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SDF-1-induced activation of ERK enhances HIV-1 expression.
    Montes M; Tagieva NE; Heveker N; Nahmias C; Baleux F; Trautmann A
    Eur Cytokine Netw; 2000 Sep; 11(3):470-7. PubMed ID: 11022134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.
    Spina CA; Prince HE; Richman DD
    J Clin Invest; 1997 Apr; 99(7):1774-85. PubMed ID: 9120023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
    Mikulak J; Gianolini M; Versmisse P; Pancino G; Lusso P; Verani A
    Virology; 2009 Jul; 390(1):37-44. PubMed ID: 19447459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-16 anti-HIV-1 therapy.
    Viglianti GA; Parada NA; Maciaszek JW; Kornfeld H; Center DM; Cruikshank WW
    Nat Med; 1997 Sep; 3(9):938. PubMed ID: 9288705
    [No Abstract]   [Full Text] [Related]  

  • 33. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells.
    Corbeil J; Richman DD
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():681-90. PubMed ID: 7897356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid.
    Zhou J; Chen CH; Aiken C
    Retrovirology; 2004 Jun; 1():15. PubMed ID: 15225375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo.
    Chapuis AG; Paolo Rizzardi G; D'Agostino C; Attinger A; Knabenhans C; Fleury S; Acha-Orbea H; Pantaleo G
    Nat Med; 2000 Jul; 6(7):762-8. PubMed ID: 10888924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.
    Wu Y; Marsh JW
    Science; 2001 Aug; 293(5534):1503-6. PubMed ID: 11520990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
    Dragic T; Trkola A; Thompson DA; Cormier EG; Kajumo FA; Maxwell E; Lin SW; Ying W; Smith SO; Sakmar TP; Moore JP
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5639-44. PubMed ID: 10779565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4.
    Pauls E; Ballana E; Moncunill G; Bofill M; Clotet B; Ramo-Tello C; Esté JA
    AIDS; 2009 Jan; 23(2):266-8. PubMed ID: 19112691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.